MRNA
Price
$34.15
Change
+$0.14 (+0.41%)
Updated
Jul 25 closing price
Capitalization
13.21B
5 days until earnings call
OKYO
Price
$2.75
Change
-$0.01 (-0.36%)
Updated
Jul 25 closing price
Capitalization
103.43M
9 days until earnings call
Interact to see
Advertisement

MRNA vs OKYO

Header iconMRNA vs OKYO Comparison
Open Charts MRNA vs OKYOBanner chart's image
Moderna
Price$34.15
Change+$0.14 (+0.41%)
Volume$5.37M
Capitalization13.21B
OKYO Pharma
Price$2.75
Change-$0.01 (-0.36%)
Volume$28.74K
Capitalization103.43M
MRNA vs OKYO Comparison Chart in %
Loading...
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MRNA vs. OKYO commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MRNA is a StrongBuy and OKYO is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 27, 2025
Stock price -- (MRNA: $34.15 vs. OKYO: $2.75)
Brand notoriety: MRNA: Notable vs. OKYO: Not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MRNA: 53% vs. OKYO: 13%
Market capitalization -- MRNA: $13.21B vs. OKYO: $103.43M
MRNA [@Biotechnology] is valued at $13.21B. OKYO’s [@Biotechnology] market capitalization is $103.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MRNA’s FA Score shows that 1 FA rating(s) are green whileOKYO’s FA Score has 0 green FA rating(s).

  • MRNA’s FA Score: 1 green, 4 red.
  • OKYO’s FA Score: 0 green, 5 red.
According to our system of comparison, MRNA is a better buy in the long-term than OKYO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MRNA’s TA Score shows that 6 TA indicator(s) are bullish while OKYO’s TA Score has 2 bullish TA indicator(s).

  • MRNA’s TA Score: 6 bullish, 4 bearish.
  • OKYO’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MRNA is a better buy in the short-term than OKYO.

Price Growth

MRNA (@Biotechnology) experienced а +9.25% price change this week, while OKYO (@Biotechnology) price change was -8.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.60%. For the same industry, the average monthly price growth was +17.32%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

MRNA is expected to report earnings on Aug 01, 2025.

OKYO is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+7.60% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRNA($13.2B) has a higher market cap than OKYO($103M). OKYO YTD gains are higher at: 139.151 vs. MRNA (-17.869).
MRNAOKYOMRNA / OKYO
Capitalization13.2B103M12,816%
EBITDA-3.2BN/A-
Gain YTD-17.869139.151-13%
P/E RatioN/AN/A-
Revenue3.14BN/A-
Total Cash5.98BN/A-
Total Debt745MN/A-
FUNDAMENTALS RATINGS
MRNA: Fundamental Ratings
MRNA
OUTLOOK RATING
1..100
33
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
51
P/E GROWTH RATING
1..100
2
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MRNAOKYO
RSI
ODDS (%)
Bearish Trend 3 days ago
75%
Bearish Trend 3 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
77%
Bearish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
Bearish Trend 3 days ago
65%
MACD
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
56%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 12 days ago
88%
Declines
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 3 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
MRNA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OKYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OILD12.340.15
+1.23%
MicroSectorsTM Ol&Gs E&P -3X Inv Lg ETNs
REGL84.250.70
+0.84%
ProShares S&P MidCap 400 Dividend Arst
UWM40.470.26
+0.65%
ProShares Ultra Russell2000
JFLI50.030.09
+0.19%
JPMorgan Flexible Income ETF
GHYB45.32N/A
+0.01%
Goldman Sachs Access Hi Yld Corp Bd ETF

MRNA and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRNA has been loosely correlated with ARCT. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MRNA jumps, then ARCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRNA
1D Price
Change %
MRNA100%
+0.41%
ARCT - MRNA
51%
Loosely correlated
-0.07%
BNTX - MRNA
50%
Loosely correlated
+0.65%
NVAX - MRNA
46%
Loosely correlated
-2.23%
CRSP - MRNA
46%
Loosely correlated
-1.97%
ALLO - MRNA
45%
Loosely correlated
-0.66%
More

OKYO and

Correlation & Price change

A.I.dvisor tells us that OKYO and XRTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that OKYO and XRTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKYO
1D Price
Change %
OKYO100%
-0.36%
XRTX - OKYO
30%
Poorly correlated
-2.91%
ACUT - OKYO
28%
Poorly correlated
+6.80%
DYN - OKYO
26%
Poorly correlated
+7.68%
MRNA - OKYO
26%
Poorly correlated
+0.41%
NXTC - OKYO
26%
Poorly correlated
+17.30%
More